Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 5, 2026 · Filed Oct 8, 2026
A Castle Biosciences director sold $114K of Castle Biosciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$113,740
Shares × reported transaction price
67 days after results of Jul 30, 2026, 31 days before results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $36.65 on Oct 5, 2026, 102% above its 52-week low and 15% below its high, after an 11% rise over the previous 30 trading days
52-week range $18.15 (May 13, 2026) to $43.04 (Jan 26, 2026), 74% of the way up, from 250 adjusted closes. 30 trading days earlier: $32.93 on Aug 20, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | −0.3% | +0.6% |
| 30 days | +2.0% | −2.7% | +4.7% |
Past results only. Not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
